Waka Yokoyama

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.

No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.

Journal: International journal of rheumatic diseases

Published: April 19, 2018

Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy.

Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy.

Journal: Modern rheumatology

Published: December 07, 2016

Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.

Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.

Journal: Modern rheumatology

Published: November 17, 2016

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.

Journal: Arthritis research & therapy

Published: August 26, 2016

High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.

High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.

Journal: Modern rheumatology

Published: December 16, 2015

Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.

Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.

Journal: BMJ case reports

Published: August 03, 2014

Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.

Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.

Journal: Arthritis research & therapy

Published: May 07, 2014

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.

Journal: Arthritis research & therapy

Published: April 11, 2014

Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).

Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).

Journal: Rheumatology (Oxford, England)

Published: April 02, 2014

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.

Journal: BMC musculoskeletal disorders

Published: December 12, 2013

CCL18 activates fibroblast-like synoviocytes in patients with rheumatoid arthritis.

CCL18 activates fibroblast-like synoviocytes in patients with rheumatoid arthritis.

Journal: The Journal of rheumatology

Published: June 04, 2013

Necessity of lysophosphatidic acid receptor 1 for development of arthritis.

Necessity of lysophosphatidic acid receptor 1 for development of arthritis.

Journal: Arthritis and rheumatism

Published: December 11, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026